Phase 4
N=60
Theracal Pulpotomy in Primary Molars
Deep Caries
Bottom Line
View on ClinicalTrials.gov: NCT04397094 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jul 2020
Primary outcome: Primary: Clinical Examination — 30; 30 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Theracal LC (Drug); Formocresol (Drug)
- Age
- Pediatric · 4+ yrs
- Sex
- All
- Sponsor
- Ain Shams University
- Primary completion
- Mar 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Examination |
30; 30 | — |
| SECONDARY Radiographic Examination |
30; 30 | — |
Summary
Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.
Eligibility Criteria
Inclusion Criteria
- healthy, cooperative children
- mandibular primary molars with vital pulp exposures
Exclusion Criteria
- clinical or radiographic evidence of irreversible pulpitis
- physiological root resorption
Data sourced from ClinicalTrials.gov (NCT04397094). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.